Company Filing History:
Years Active: 2010-2014
Title: Alaka Mullick: Innovator in Inducible Expression Systems
Introduction
Alaka Mullick is a prominent inventor based in Montreal, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of inducible expression systems. With a total of 6 patents to his name, Mullick's work has advanced the understanding and application of genetic engineering.
Latest Patents
One of Mullick's latest patents is focused on the reverse cumate repressor mutant. This innovation involves the exploitation of the p-cym operon, leading to the development of novel expression systems and components. The disclosed CymR variants exhibit reverse DNA binding activity, which allows for increased affinity for DNA in the presence of effector molecules such as cumene. Additionally, the patent details the use of these variants and fusion proteins in controlling and expressing polynucleotides. The CymR variant specifically comprises a 142Glu to 142Gly single point mutation of the wild type CymR.
Career Highlights
Alaka Mullick is affiliated with the National Research Council of Canada, where he continues to push the boundaries of research in biotechnology. His work has been instrumental in creating more efficient systems for gene expression, which can have far-reaching implications in various fields, including medicine and agriculture.
Collaborations
Throughout his career, Mullick has collaborated with notable colleagues such as Bernard Massie and Peter C K Lau. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Alaka Mullick's contributions to the field of biotechnology, particularly through his patents on inducible expression systems, highlight his role as a leading inventor. His work not only advances scientific knowledge but also paves the way for future innovations in genetic engineering.